Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Effects of the beta3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: relevance to its antidepressant/anxiolytic-like profile.

Claustre Y, Leonetti M, Santucci V, Bougault I, Desvignes C, Rouquier L, Aubin N, Keane P, Busch S, Chen Y, Palejwala V, Tocci M, Yamdagni P, Didier M, Avenet P, Le Fur G, Oury-Donat F, Scatton B, Steinberg R.

Neuroscience. 2008 Oct 2;156(2):353-64. doi: 10.1016/j.neuroscience.2008.07.011. Epub 2008 Jul 11.

PMID:
18691638
2.

Effects of the vasopressin (V1b) receptor antagonist, SSR149415, and the corticotropin-releasing factor 1 receptor antagonist, SSR125543, on FG 7142-induced increase in acetylcholine and norepinephrine release in the rat.

Claustre Y, Rouquier L, Desvignes C, Leonetti M, Montégut J, Aubin N, Allouard N, Bougault I, Oury-Donat F, Steinberg R.

Neuroscience. 2006 Sep 1;141(3):1481-8. Epub 2006 Jun 15.

PMID:
16781820
3.

SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist. I: Neurochemical and electrophysiological profile.

Claustre Y, Peretti DD, Brun P, Gueudet C, Allouard N, Alonso R, Lourdelet J, Oblin A, Damoiseau G, Françon D, Suaud-Chagny MF, Steinberg R, Sevrin M, Schoemaker H, George P, Soubrié P, Scatton B.

Neuropsychopharmacology. 2003 Dec;28(12):2064-76.

4.

SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair.

Ferzaz B, Brault E, Bourliaud G, Robert JP, Poughon G, Claustre Y, Marguet F, Liere P, Schumacher M, Nowicki JP, Fournier J, Marabout B, Sevrin M, George P, Soubrie P, Benavides J, Scatton B.

J Pharmacol Exp Ther. 2002 Jun;301(3):1067-78.

PMID:
12023539
5.

The preclinical pharmacologic profile of tiapride.

Scatton B, Cohen C, Perrault G, Oblin A, Claustre Y, Schoemaker H, Sanger DJ, Rouquier L, Porsolt R.

Eur Psychiatry. 2001 Jan;16 Suppl 1:29s-34s.

PMID:
11520476
6.

Discriminative stimulus effects of drugs acting at GABA(A) receptors: differential profiles and receptor selectivity.

Sanger DJ, Griebel G, Perrault G, Claustre Y, Schoemaker H.

Pharmacol Biochem Behav. 1999 Oct;64(2):269-73. Review.

PMID:
10515302
7.

Amisulpride: from animal pharmacology to therapeutic action.

Scatton B, Claustre Y, Cudennec A, Oblin A, Perrault G, Sanger DJ, Schoemaker H.

Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S29-36. Review.

PMID:
9218165
8.

Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.

Schoemaker H, Claustre Y, Fage D, Rouquier L, Chergui K, Curet O, Oblin A, Gonon F, Carter C, Benavides J, Scatton B.

J Pharmacol Exp Ther. 1997 Jan;280(1):83-97.

PMID:
8996185
9.
10.

In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.

Benavides J, Schoemaker H, Dana C, Claustre Y, Delahaye M, Prouteau M, Manoury P, Allen J, Scatton B, Langer SZ, et al.

Arzneimittelforschung. 1995 May;45(5):551-8.

PMID:
7612054
11.
12.

Muscarinic receptor-mediated increase in extracellular inositol 1,4,5-trisphosphate levels in the rat hippocampus: an in vivo microdialysis study.

Minisclou C, Rouquier L, Benavides J, Scatton B, Claustre Y.

J Neurochem. 1994 Feb;62(2):557-62.

PMID:
8294918
13.
14.

5-HT1C receptors mediate phosphoinositide turnover activation in the immature rat hippocampus.

Claustre Y, Eudeline B, Benavides J, Scatton B.

Eur J Pharmacol. 1992 Jan 14;225(1):37-41.

PMID:
1311687
15.

Effect of the putative 5-HT1A receptor antagonist NAN-190 on rat brain serotonergic transmission.

Claustre Y, Rouquier L, Serrano A, Bénavidès J, Scatton B.

Eur J Pharmacol. 1991 Oct 29;204(1):71-7.

PMID:
1666563
17.
18.

5-HT1A receptor agonists inhibit carbachol-induced stimulation of phosphoinositide turnover in the rat hippocampus.

Claustre Y, Bénavidès J, Scatton B.

Eur J Pharmacol. 1988 Apr 27;149(1-2):149-53.

PMID:
2840296
19.

Pharmacological characterization of serotonin-stimulated phosphoinositide turnover in brain regions of the immature rat.

Claustre Y, Rouquier L, Scatton B.

J Pharmacol Exp Ther. 1988 Mar;244(3):1051-6.

PMID:
2855237
20.
21.

Fengabine, a novel antidepressant GABAergic agent. II. Effect on cerebral noradrenergic, serotonergic and GABAergic transmission in the rat.

Scatton B, Lloyd KG, Zivkovic B, Dennis T, Claustre Y, Dedek J, Arbilla S, Langer SZ, Bartholini G.

J Pharmacol Exp Ther. 1987 Apr;241(1):251-7.

PMID:
3033204
22.

Pharmacological studies on stress-induced increase in frontal cortical dopamine metabolism in the rat.

Claustre Y, Rivy JP, Dennis T, Scatton B.

J Pharmacol Exp Ther. 1986 Aug;238(2):693-700.

PMID:
2874216
23.

Zolpidem, a novel nonbenzodiazepine hypnotic. II. Effects on cerebellar cyclic GMP levels and cerebral monoamines.

Scatton B, Claustre Y, Dennis T, Nishikawa T.

J Pharmacol Exp Ther. 1986 May;237(2):659-65.

PMID:
2871179
24.

Characterization of [3H]paroxetine binding to rat cortical membranes.

Habert E, Graham D, Tahraoui L, Claustre Y, Langer SZ.

Eur J Pharmacol. 1985 Nov 26;118(1-2):107-14.

PMID:
2935409
26.

Substituted tetrahydro-beta-carbolines are possible candidates as endogenous ligand of the [3H]imipramine recognition site.

Langer SZ, Raisman R, Tahraoui L, Scatton B, Niddam R, Lee CR, Claustre Y.

Eur J Pharmacol. 1984 Feb 10;98(1):153-4. No abstract available.

PMID:
6325207
27.

Alterations of noradrenaline and serotonin uptake and metabolism in chronic cobalt-induced epilepsy in the rat.

Trottier S, Claustre Y, Caboche J, Dedek J, Chauvel P, Nassif S, Scatton B.

Brain Res. 1983 Aug 8;272(2):255-62.

PMID:
6193838

Supplemental Content

Loading ...
Support Center